ACUTE MYOCARDIAL ISCHEMIA and infarction are dynamic processes and information on the size and progression of infarction with time is potentially important in coronary care. The use of continuous vectorcardiography (VCG) to monitor patients was suggested by Hodges et al., ' and has been further adapted for the evaluation of acute myocardial infarction (AMI).2-5 Serial analysis of spatial VCGs permits a simple and convenient determination of temporal and quantitative changes in the QRS complex and ST segment. In contrast to precordial electrocardiographic mapping, which applies quantitatively only to anterior myocardial infarcts, spatial VCG can be used irrespective of infarct location since the electromotive forces are reduced to three equipotential orthogonal leads.
early phase of an AMI and continuous recording is necessary to capture the maximum deviation. In animal experiments this value defines the area of the reversible injury and predicts the ultimate infarct size.6'7 QRS changes closely reflect myocardial cell death8 and serial analysis of VCGs may provide important information about the rate and extent of infarction. The vectorial deviations of the QRS complex from preinfarction values theoretically reflect the loss of electrically active myocardium due to irreversible damage.9 10 This vector difference has been shown to correlate with morphometric measurements of infarct size in animal experiments."' 12 In the clinical setting the premorbid reference VCG is rarely available. However, the onset of symptoms does not necessarily mean that the necrotic process has started but simply that the patient has ongoing myocardial ischemia. Necrosis, as reflected by changes in the QRS complex, may develop after various time intervals, but usually begins developing after 1 to 2 hr.'3 Thus, when obtained early, the first QRS complex may prove valid as a reference value.
DIAGNOSTIC METHODS-MYOCARDIAL INFARCTION
In this study we have examined the possible usefulness of continuous recordings of spatial ST and QRS vectors in the assessment of the evolution of ischemia and necrosis in AMI and compared these indices with the cumulative release of myocardial creatine kinase (CK).
represent the Cartesian coordinates of the summation vector for each beat. The reproducibility of this procedure was tested and gave a coefficient of variation of 4% for repeated measure ) where XX,XY, and EZ denote lead sums from onset to offset of QRS complex, r is the reference beat, and i is the current beat.
The QRS-VD and ST-VM were plotted as a function of time from onset of symptoms. From these graphs the following parameters were determined: maximal ST-VM recorded during the registration period (ST-VMmax), maximal QRS-VD (QRSVDmax), and the duration of the QRS vector evolution from onset of symptoms to plateau level (QRS evolution time). Polyphasic evolution of the QRS vector changes was arbitrarily defined as a new permanent change of at least 10%, preceded by a plateau of more than 2 hr duration.
Statistical computations were performed with the 
Results
The sampling of CK and recording of VCGs began on average 2.55 (0 to 4.0) hr after onset of symptoms.
Monophasic infarct evolution. Monophasic infarct evolution as reflected by the cumulative CK release and the QRS-VD was found in 35 of the 60 patients. Figure 1 , A, illustrates a typical monophasic infarct evolution. Average CKmax for the monophasic infarcts was 3197 (I 10 to 7900) IU/1 and QRS-VDmax was 25 .0 (2.6 to 68.9) ,uV sec. The average CK release time was 27.4 (8.0 to 50.0) hr and was considerably longer than the QRS evolution time of 9.7 (1.0 to 19.0) hr (p < .001).
The relationship between CKmax and QRSVDmax is shown in figure 2 , and suggests an association between the two independent indices of myocardial necrosis (r = .65). The average ST-VMmaX for monophasic infarcts was 0.264 (0.050 to 0.590) mV and was reduced by 27% after 1 hr (p < .001). A close correlation was obtained between ST-VMmax and QRS-VDmax (r = .80; Biphasic infarct evolution. Biphasic infarct evolution was found in 25 patients (42%); in 15 The recordings were started 3.5 hr after onset of symptoms. ' maximal after 6 hr, the QRS-VD reached a plateau level afte the CK release was complete after 31 hr. B, Biphasic infarc Recordings were started 3 hr after onset of symptoms. S maximal at start of recording, with a second rise after 10 hi leveled off after 8 hr, followed by a recurrent increase to a f after 17 hr. Similar but markedly delayed biphasic evoluti served for cumulative CK, with plateau levels after 27 an was evident from the QRS-VD curves. In on of these patients was a biphasic course obse both parameters. Figure 1 One problem associated with infarct sizing from QRS changes is the lack of a preinfarction reference. In dog experiments Hillis et al. 13 found that the size of the Q wave at 2 hr after occlusion was about a seventh of the final Q wave at 24 hr. However, myocardial infarction evolves more rapidly in dogs than in humans. Separate examination of the patients admitted within or after 2 hr of onset of symptoms did not show any significant differences in the regression of QRS- About 40% of the patients showed electrocardiographic or enzymatic evidence of biphasic infarct evolution. Different pathophysiologic mechanisms may be reflected by the stepwise changes in the respective curves. Short-term changes in left ventricular volume or thinning of the infarcted area without extension of the actual necrosis have been shown to produce change in the QRS complex.40'4' In the present study, 10 patients (17%) had a second permanent change in the QRS-VD that was not accompanied by further CK release, and this presumably reflected infarct expansion. Seven patients (12%) demonstrated a recurrent rise in QRS-VD and cumulative CK release that strongly suggested infarct extension. In eight patients (13%) secondary CK release was observed without associated QRS changes. This may be explained by insufficient VCG observation time or increase in plasma CK independent of infarct extension caused by changes in plasma volume or increased washout of extravascular CK. Thus, between 12% and 25% of the patients in this study showed infarct extension. This is close to the incidence reported in previous studies 30 40, 42 The observation that ST-VMmax correlated better with QRS-VDmax and CKma of the second plateau than of the first plateau indicates that the ultimate size of the necrosis is defined by the ischemia early after coronary occlusion. However, part of the jeopardized myocardium will not be irreversibly injured until much later, as indicated by the QRS evolution time of 9.2 hr to the first plateau vs 17.6 hr to the second plateau. This may be due to nonuniform residual flow that results in different capacity for survival. This has considerable bearing on the use of early intervention to limit infarct size.
Patients with anterior wall infarcts tended to have a higher ST-VMma, QRS-VDm ,,,, and CKmax than inferior infarcts. This is probably due to the fact that in humans a larger myocardial mass is supplied by the left anterior descending artery than by the right circumflex artery. The QRS evolution time was not related to infarct size, but the time to complete the infarction was shorter in anterior than in inferior infarcts (table 2), confirming the results of a previous study. 2 No single index presently available can accurately assess the progression of the ischemic injury and the ultimate infarct size. The changes in the VCG and the enzyme release therefore have to be used as complementary indices. The present study shows that these indices may be particularly valuable in trials of treatment aimed at limiting infarct size. Continuous analysis of the VCG permits semiquantitative assessment of the evolving myocardial ischemia and infarction. Because infarct size varies over a wide range a large patient group is needed to detect infarct reduction. The group size can be reduced if the method of comparing the infarct size predicted from initial ST-VM with the observed size as measured by CK release and QRS-VD is used. From this study it may be calculated that to detect a 30% reduction of infarct size predicted from the ST-VMmax obtained early, a minimum of 60 patients per group will be required to show a statistical difference at a = .05 and 1-13 (power) = .80.
Since the QRS-VD on average evolves in less than 10 hr early intervention has to be started within 4 to 6 hr after onset of symptoms in order to prove effective.
